Login

Timothy Morris - CFO, Head of Business Development, AcelRx Pharmaceuticals Inc 00:00:00

Share On Facebook Share On Twitter

Discuss the specialty pharmaceutical company

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Bob Miner discusses the future of gold prices at $2750; Peter Brereton is the President and CEO of TECSYS Inc|Peter Brereton, President and CEO of TECSYS Inc
00:10:00
Decoding Market Anomalies: Investment Strategies Amid Economic Shifts | Karen Karniol-Tambour, CO-CIO , Bridgewater Associates LP.
00:10:00
Tom Wolfe on 'Back to Blood' and Modern Identity
01:10:00
CEO Insights on Government Tenants and Portfolio Strategy | Roger Waesche Jr., CEO, Corporate Office Properties Trust.
00:10:00
Daniel Dines of UiPath presents 10 AI innovations poised to change lives at UiPath FORWARD VI 2023.
00:10:00
Sumitomo Bank's Strategic Vision for Global Expansion and Economic Resilience | Jun Ohta, CEO , Sumitomo Mitsui Financial Group.
00:10:00
From Romania to NASA to Silicon Valley|Oana Olteanu,Partner,SignalFire
00:10:00
Cohen & Steers: Expanding Leadership in Global Real Assets | Bob Steers, Executive Chairman , Cohen & Steers Inc.
00:10:00
Mark from A Rupa Updates on 2019 Plans and Projects at Vancouver Resource Investment Conference
00:10:00
W Resources: Developing Europe's Largest Tungsten Mine at La Parrilla
00:10:00
Demystifying Finance Industry Designations: CFP®, CFA, and CPA Explained | Elizabeth Hutton - VICE PRESIDENT, FINANCIAL PLANNER of Howe & Rusling, Inc.
00:10:00
Navigating Social Change and Investment: Insights from Paul Niven, Fund Manager at F&C Investment Trust

© 2017 - Neuhu+